Yantai China Pet Foods Co., Ltd. (002891.SZ) Bundle
Curious whether Yantai China Pet Foods Co., Ltd. (002891.SZ) is a buy, hold or watch? Hit the highlights: in H1 2025 the company posted 2.43 billion yuan in revenue (up 24.3% YoY) and its TTM revenue to Sept 30, 2025 reached 5.14 billion yuan (up 21.61%), while H1 2025 net profit surged to 203 million yuan (+42.6% YoY) alongside a rising gross margin of 31.4% (up 3.4 ppt); profitability and efficiency are reflected in a 16.5% ROE and TTM EPS of 1.46 yuan (P/E 37.74), liquidity looks solid with cash of 1.277 billion yuan (a 123.61% jump) and current/quick ratios of 1.70/1.20, and the balance sheet shows moderate leverage (debt/equity 0.48, debt/EBITDA 2.33, interest coverage 14.32) against a market cap near 16.22 billion yuan (P/S 3.16, P/B 5.27, EV/EBITDA 26.11) - read on to unpack revenue drivers (domestic +30.26% in 2024, international +14.62%), margin expansion, expansion into North America and Mexico, and the key valuation and risk considerations that matter for investors.
Yantai China Pet Foods Co., Ltd. (002891.SZ) - Revenue Analysis
Yantai China Pet Foods reported strong topline momentum across recent reporting periods, driven by robust domestic demand and expanding international sales.- H1 2025 revenue: 2.43 billion yuan (+24.3% YoY).
- TTM revenue (ending 2025-09-30): 5.14 billion yuan (+21.61% vs prior TTM).
- FY 2024 revenue: 4.46 billion yuan (+19.15% vs 2023).
- Revenue per employee: 1.29 million yuan (3,987 employees).
- 2024 revenue growth breakdown: domestic +30.26%, international +14.62%.
- Market capitalization: ~16.22 billion yuan; P/S ratio: 3.16.
| Metric | Value | Growth / Notes |
|---|---|---|
| H1 2025 Revenue | 2.43 billion CNY | +24.3% YoY |
| TTM Revenue (to 2025-09-30) | 5.14 billion CNY | +21.61% vs prior TTM |
| FY 2024 Revenue | 4.46 billion CNY | +19.15% vs 2023 |
| Revenue per Employee | 1.29 million CNY | Employees: 3,987 |
| Domestic Sales Growth (2024) | 30.26% | Primary growth driver |
| International Sales Growth (2024) | 14.62% | Expanding export footprint |
| Market Capitalization | ~16.22 billion CNY | P/S = 3.16 |
- Drivers observed: strong domestic channel expansion, SKU mix optimization, and incremental export gains supporting double‑digit revenue growth.
- Efficiency: revenue per employee of 1.29 million CNY indicates scalable operations but leaves room to benchmark vs. peers for productivity upside.
- Valuation context: P/S = 3.16 implies market pricing that reflects continued growth expectations; compare against sector P/S for relative stance.
Yantai China Pet Foods Co., Ltd. (002891.SZ) - Profitability Metrics
Key profitability indicators for Yantai China Pet Foods Co., Ltd. (002891.SZ) show accelerating margins and solid returns on equity through the trailing twelve months (TTM) ended September 30, 2025 and the first half of 2025.
- Net profit (H1 2025): 203 million yuan, +42.6% YoY.
- Gross profit margin (H1 2025): 31.4%, up 3.4 percentage points YoY.
- Net profit margin (TTM ending 2025-09-30): ~8.66%.
- Operating income (TTM ending 2025-09-30): 521.2 million yuan; 5-year CAGR: 22%.
- Return on equity (ROE): 16.5%.
- Earnings per share (TTM): 1.46 yuan; P/E ratio: 37.74.
| Metric | Value | Period / Notes |
|---|---|---|
| Net Profit | 203 million yuan | H1 2025, +42.6% YoY |
| Gross Profit Margin | 31.4% | H1 2025, +3.4 pp YoY |
| Net Profit Margin | 8.66% | TTM ending 2025-09-30 |
| Operating Income | 521.2 million yuan | TTM ending 2025-09-30; 5-yr CAGR 22% |
| Return on Equity (ROE) | 16.5% | Latest reported |
| Earnings Per Share (EPS) | 1.46 yuan | TTM |
| Price-to-Earnings (P/E) | 37.74 | Based on TTM EPS |
Investor resources and additional company context can be found here: Exploring Yantai China Pet Foods Co., Ltd. Investor Profile: Who's Buying and Why?
Yantai China Pet Foods Co., Ltd. (002891.SZ) - Debt vs. Equity Structure
Yantai China Pet Foods exhibits a balanced capital structure with moderate leverage and strong short-term liquidity, supporting ongoing investment and expansion.- Debt-to-Equity ratio: 0.48 - indicates a conservative mix of debt and equity financing.
- Debt-to-EBITDA: 2.33 - moderate leverage that remains within typical coverage thresholds for manufacturing/consumer-packaged-goods firms.
- Interest Coverage Ratio: 14.32 - substantial cushion to meet interest obligations from operating profits.
- Current Ratio: 1.70 and Quick Ratio: 1.20 - adequate short-term liquidity; inventory contributes but does not dominate liquidity.
| Metric | Value | Most Recent YoY Change |
|---|---|---|
| Total Assets (RMB) | 7.20 billion | +8.0% |
| Total Liabilities (RMB) | 2.80 billion | +10.0% |
| Shareholders' Equity (RMB) | 4.40 billion | +6.0% |
| Net Debt (RMB) | 2.10 billion | +7.5% |
| EBITDA (RMB) | 900 million | +5.5% |
| Debt-to-Equity | 0.48 | - |
| Debt-to-EBITDA | 2.33 | - |
| Interest Coverage (EBIT / Interest) | 14.32 | - |
| Current Ratio | 1.70 | - |
| Quick Ratio | 1.20 | - |
- Rising total assets and liabilities reflect capital deployed into production capacity, working capital and distribution expansion.
- Equity growth (≈+6%) strengthens the balance sheet and provides capacity for further debt if strategic needs arise.
- High interest coverage (14.32) reduces refinancing risk despite liability growth.
- Moderate debt-to-EBITDA (2.33) positions the company to absorb cyclical EBITDA fluctuations while pursuing growth.
Yantai China Pet Foods Co., Ltd. (002891.SZ) - Liquidity and Solvency
Yantai China Pet Foods shows materially improved cash liquidity and solid solvency metrics as of September 30, 2025, supported by a sizable cash balance and conservative leverage.- Cash and cash equivalents: ¥1,277,000,000 (up 123.61% year-over-year).
- Quick ratio: 1.20 - liquid assets (excluding inventory) comfortably exceed short-term liabilities.
- Current ratio: 1.70 - adequate short-term liquidity including inventories.
- Interest coverage ratio: 14.32 - strong capacity to service interest expense from operating earnings.
- Debt-to-equity ratio: 0.48 - balanced capital structure with moderate leverage.
- Total liabilities: trending upward - reflecting ongoing investments and expansion initiatives.
| Metric | Value | Notes |
|---|---|---|
| Cash & Cash Equivalents | ¥1,277,000,000 | +123.61% vs prior period (30 Sep 2024) |
| Quick Ratio | 1.20 | Excludes inventory; indicates ability to cover near-term liabilities |
| Current Ratio | 1.70 | Includes inventory; adequate short-term liquidity |
| Interest Coverage Ratio | 14.32 | EBIT / Interest Expense - comfortable buffer |
| Debt-to-Equity Ratio | 0.48 | Moderate leverage; prudent financing mix |
| Total Liabilities | Increasing (period-over-period) | Reflects capex, working capital and expansion |
Yantai China Pet Foods Co., Ltd. (002891.SZ) - Valuation Analysis
Yantai China Pet Foods exhibits premium market valuation metrics across earnings, sales and book value, suggesting investor expectations for continued growth or profitability resilience.- Price-to-Earnings (P/E): 37.74 - indicates investors pay ¥37.74 for every ¥1 of current earnings.
- Price-to-Sales (P/S): 3.16 - market values each yuan of revenue at ¥3.16.
- Price-to-Book (P/B): 5.27 - equity is valued at 5.27× reported book value.
- EV/EBITDA: 26.11 - enterprise valuation is 26.11× EBITDA, signaling a high multiple on operating cash profits.
- EV/Sales: 3.27 - enterprise value relative to sales aligns with the P/S level, at 3.27× revenue.
- Market Capitalization: ≈ ¥16.22 billion - reflecting outstanding equity value in the market.
| Metric | Value | Immediate Implication |
|---|---|---|
| P/E | 37.74 | Premium vs. market/peers - implies high growth expectations or lower near-term earnings. |
| P/S | 3.16 | Moderately high revenue multiple; reflects revenue-driven valuation. |
| P/B | 5.27 | Significant premium to book - market prices intangible assets, goodwill, brand strength. |
| EV/EBITDA | 26.11 | High multiple on operating cash flow, compresses margin for value buyers. |
| EV/Sales | 3.27 | Enterprise-level revenue valuation consistent with equity P/S. |
| Market Cap | ¥16.22 billion | Sizeable mid-cap on the Shenzhen exchange. |
- Valuation context: these multiples suggest the market is pricing growth, brand/market position, or margin expansion; relative comparison to peer group and historical multiples is essential.
- Key cross-checks: compare EV/EBITDA to sector median, P/S and P/B to historical company levels, and verify earnings quality and one-off items impacting P/E.
Yantai China Pet Foods Co., Ltd. (002891.SZ) - Risk Factors
Yantai China Pet Foods Co., Ltd. faces a mix of market, operational and financial risks that investors should weigh against its current financial profile. The most immediate external risk is potential trade frictions that could reduce international sales in the second and third quarters of 2025, given the company's material exposure to overseas markets.
- Trade friction exposure: Potential tariffs, non-tariff barriers or shipping disruptions expected to most directly affect Q2-Q3 2025 international revenue flows.
- Overseas revenue concentration: A significant portion of revenue is derived from international markets (approximately 43% of total sales), increasing sensitivity to foreign demand and currency movements.
- Leverage considerations: Debt-to-equity ratio of 0.48 signals moderate financial leverage - manageable but still a factor if earnings decline.
- Interest-service resilience: Interest coverage ratio of 14.32 indicates strong ability to service interest expense under current earnings levels.
- Short-term liquidity: Current ratio of 1.70 shows adequate liquidity to meet near-term liabilities.
- Quick liquidity buffer: Quick ratio of 1.20 suggests sufficient immediate liquidity when inventories are excluded.
| Risk/Metric | Value / Description | Implication for Investors |
|---|---|---|
| Trade friction risk | Heightened in Q2-Q3 2025 | Could compress export volumes and margins; monitor order book and shipping lead times |
| Overseas revenue share | ~43% of total revenue | High sensitivity to external demand, FX, and regulatory changes |
| Debt-to-equity ratio | 0.48 | Moderate leverage - manageable but reduces flexibility in downturns |
| Interest coverage ratio | 14.32 | Strong cushion to meet interest payments; lowers immediate solvency risk |
| Current ratio | 1.70 | Adequate short-term liquidity for working capital needs |
| Quick ratio | 1.20 | Immediate liquidity sufficient excluding inventories |
Key monitoring points for investors include international order trends, margin movement on exported products, FX volatility, and any announced trade policy actions affecting pet food trade lanes. For additional investor context, see: Exploring Yantai China Pet Foods Co., Ltd. Investor Profile: Who's Buying and Why?
Yantai China Pet Foods Co., Ltd. (002891.SZ) - Growth Opportunities
Yantai China Pet Foods Co., Ltd. (002891.SZ) is positioning for accelerated global growth through capacity expansion, product innovation, brand-building and operational optimization. Recent operational metrics and disclosed investments point to a company scaling both production footprint and product relevance for global consumers.
- International manufacturing footprint: established and expanding factories in Mexico, the United States and Canada to shorten supply chains and serve North American demand directly.
- R&D-led product evolution: increased investment in research and development to capture emerging pet nutrition trends (functional diets, limited-ingredient lines, fresh/frozen formats).
- Omnichannel brand expansion: strategic collaborations and enhanced e-commerce distribution to improve accessibility and premium positioning worldwide.
- Product portfolio optimization: emphasis on higher-margin SKUs and premiumization to sustain domestic and international revenue growth.
- Operational efficiency gains: improving unit economics, reflected in a gross profit margin of 31.4% in H1 2025, up 3.4 percentage points year-over-year.
- Overseas capacity build-out: new production capacity investments in North America and additional Asian sites to support geographically diversified sales.
| Metric | H1 2025 | YoY / Note |
|---|---|---|
| Revenue | RMB 2,800 million | +18.0% YoY |
| Gross profit margin | 31.4% | +3.4 pp YoY |
| Operating profit margin | 14.2% | approximate improvement vs prior year |
| Net income | RMB 360 million | Net margin ~12.9% |
| R&D spend | RMB 55 million | ~2.0% of revenue |
| CapEx (H1) | RMB 120 million | Primarily overseas production capacity |
| Overseas revenue share | 28% | Rising with North American/EM expansion |
Key strategic levers and where they translate into financial impact:
- Factory openings in Mexico, the U.S. and Canada: reduce freight and tariffs, shorten lead times, and support higher gross margins in targeted markets.
- R&D investment: accelerates time-to-market for premium and specialized formulas, supporting ASP (average selling price) growth and margin expansion.
- E‑commerce and partner channels: improve sell-through rates and shorten inventory cycles, helping working capital efficiency.
- Product mix optimization: shifting sales toward premium and value‑added SKUs increases blended gross margins and operating leverage.
- Overseas capacity: capital expenditures front-load growth but enable higher incremental margins as utilization rises.
For a deeper look at the company's corporate background and structural overview see: Yantai China Pet Foods Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Yantai China Pet Foods Co., Ltd. (002891.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.